Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
65
SSSGY Quote, Financials, Valuation and Earnings
Last price:
$43.34
Seasonality move
:
-1.18%
Day range:
$43.34 - $43.34
52-week range:
$36.53 - $47.15
Dividend yield:
0.35%
P/E ratio:
100.66x
P/S ratio:
3.85x
P/B ratio:
9.62x
Volume:
--
Avg. volume:
10
1-year change:
8.34%
Market cap:
$15B
Revenue:
$3.7B
EPS (TTM):
$0.43
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SSSGY
Sartorius AG
|
-- | -- | -- | -- | -- |
|
BNTX
BioNTech SE
|
$1.2B | $0.12 | -24.04% | -86.85% | $138.33 |
|
CVAC
CureVac NV
|
$25.1M | -$0.08 | 0.04% | -32.36% | $5.31 |
|
IFRX
InflaRx NV
|
$34.6K | -$0.14 | -74.55% | -16.09% | $11.24 |
|
IMTX
Immatics NV
|
$12.5M | -$0.45 | -81.87% | -704.25% | $18.75 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SSSGY
Sartorius AG
|
$43.34 | -- | $15B | 100.66x | $0.15 | 0.35% | 3.85x |
|
BNTX
BioNTech SE
|
$92.50 | $138.33 | $22.2B | 191.55x | $0.00 | 0% | 6.29x |
|
CVAC
CureVac NV
|
$4.16 | $5.31 | $936.7M | 5.82x | $0.00 | 0% | 11.56x |
|
IFRX
InflaRx NV
|
$1.11 | $11.24 | $75.2M | -- | $0.00 | 0% | 342.97x |
|
IMTX
Immatics NV
|
$10.27 | $18.75 | $1.2B | 42.21x | $0.00 | 0% | 13.72x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SSSGY
Sartorius AG
|
61.54% | 1.688 | 34.79% | 0.37x |
|
BNTX
BioNTech SE
|
1.31% | 1.267 | 1.22% | 6.78x |
|
CVAC
CureVac NV
|
3.87% | 1.835 | 3.39% | 1.84x |
|
IFRX
InflaRx NV
|
2.1% | -0.453 | 1.26% | 2.34x |
|
IMTX
Immatics NV
|
3.78% | 2.023 | 1.86% | 6.97x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SSSGY
Sartorius AG
|
$459.5M | $172.6M | 2.49% | 5.43% | 17.52% | -$73.1M |
|
BNTX
BioNTech SE
|
$1.6B | $743.4M | -2.96% | -3.01% | 41.89% | $785.5M |
|
CVAC
CureVac NV
|
$57.9M | -$11.6M | 19.52% | 20.55% | -18.33% | $31.6M |
|
IFRX
InflaRx NV
|
-$89.2K | -$11.7M | -80.95% | -82.01% | -42057.91% | -$11.4M |
|
IMTX
Immatics NV
|
-- | -$63.9M | -24.18% | -25.21% | -1053.82% | -$56.2M |
Sartorius AG vs. Competitors
-
Which has Higher Returns SSSGY or BNTX?
BioNTech SE has a net margin of 7.35% compared to Sartorius AG's net margin of -1.89%. Sartorius AG's return on equity of 5.43% beat BioNTech SE's return on equity of -3.01%.
Company Gross Margin Earnings Per Share Invested Capital SSSGYSartorius AG46.63% $0.15 $9.5B BNTXBioNTech SE90.24% -$0.14 $22B -
What do Analysts Say About SSSGY or BNTX?
Sartorius AG has a consensus price target of --, signalling downside risk potential of --. On the other hand BioNTech SE has an analysts' consensus of $138.33 which suggests that it could grow by 49.55%. Given that BioNTech SE has higher upside potential than Sartorius AG, analysts believe BioNTech SE is more attractive than Sartorius AG.
Company Buy Ratings Hold Ratings Sell Ratings SSSGYSartorius AG0 0 0 BNTXBioNTech SE14 5 0 -
Is SSSGY or BNTX More Risky?
Sartorius AG has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison BioNTech SE has a beta of 1.295, suggesting its more volatile than the S&P 500 by 29.477%.
-
Which is a Better Dividend Stock SSSGY or BNTX?
Sartorius AG has a quarterly dividend of $0.15 per share corresponding to a yield of 0.35%. BioNTech SE offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sartorius AG pays 32.05% of its earnings as a dividend. BioNTech SE pays out -- of its earnings as a dividend. Sartorius AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SSSGY or BNTX?
Sartorius AG quarterly revenues are $985.3M, which are smaller than BioNTech SE quarterly revenues of $1.8B. Sartorius AG's net income of $72.5M is higher than BioNTech SE's net income of -$33.5M. Notably, Sartorius AG's price-to-earnings ratio is 100.66x while BioNTech SE's PE ratio is 191.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sartorius AG is 3.85x versus 6.29x for BioNTech SE. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SSSGYSartorius AG3.85x 100.66x $985.3M $72.5M BNTXBioNTech SE6.29x 191.55x $1.8B -$33.5M
-
Which has Higher Returns SSSGY or CVAC?
CureVac NV has a net margin of 7.35% compared to Sartorius AG's net margin of -5832.47%. Sartorius AG's return on equity of 5.43% beat CureVac NV's return on equity of 20.55%.
Company Gross Margin Earnings Per Share Invested Capital SSSGYSartorius AG46.63% $0.15 $9.5B CVACCureVac NV91.57% $1.41 $1.1B -
What do Analysts Say About SSSGY or CVAC?
Sartorius AG has a consensus price target of --, signalling downside risk potential of --. On the other hand CureVac NV has an analysts' consensus of $5.31 which suggests that it could grow by 27.96%. Given that CureVac NV has higher upside potential than Sartorius AG, analysts believe CureVac NV is more attractive than Sartorius AG.
Company Buy Ratings Hold Ratings Sell Ratings SSSGYSartorius AG0 0 0 CVACCureVac NV1 3 0 -
Is SSSGY or CVAC More Risky?
Sartorius AG has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CureVac NV has a beta of 1.771, suggesting its more volatile than the S&P 500 by 77.063%.
-
Which is a Better Dividend Stock SSSGY or CVAC?
Sartorius AG has a quarterly dividend of $0.15 per share corresponding to a yield of 0.35%. CureVac NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sartorius AG pays 32.05% of its earnings as a dividend. CureVac NV pays out -- of its earnings as a dividend. Sartorius AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SSSGY or CVAC?
Sartorius AG quarterly revenues are $985.3M, which are larger than CureVac NV quarterly revenues of $63.3M. Sartorius AG's net income of $72.5M is lower than CureVac NV's net income of $319.3M. Notably, Sartorius AG's price-to-earnings ratio is 100.66x while CureVac NV's PE ratio is 5.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sartorius AG is 3.85x versus 11.56x for CureVac NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SSSGYSartorius AG3.85x 100.66x $985.3M $72.5M CVACCureVac NV11.56x 5.82x $63.3M $319.3M
-
Which has Higher Returns SSSGY or IFRX?
InflaRx NV has a net margin of 7.35% compared to Sartorius AG's net margin of -51538.49%. Sartorius AG's return on equity of 5.43% beat InflaRx NV's return on equity of -82.01%.
Company Gross Margin Earnings Per Share Invested Capital SSSGYSartorius AG46.63% $0.15 $9.5B IFRXInflaRx NV-320.86% -$0.21 $54.4M -
What do Analysts Say About SSSGY or IFRX?
Sartorius AG has a consensus price target of --, signalling downside risk potential of --. On the other hand InflaRx NV has an analysts' consensus of $11.24 which suggests that it could grow by 912.95%. Given that InflaRx NV has higher upside potential than Sartorius AG, analysts believe InflaRx NV is more attractive than Sartorius AG.
Company Buy Ratings Hold Ratings Sell Ratings SSSGYSartorius AG0 0 0 IFRXInflaRx NV5 2 0 -
Is SSSGY or IFRX More Risky?
Sartorius AG has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison InflaRx NV has a beta of 1.459, suggesting its more volatile than the S&P 500 by 45.896%.
-
Which is a Better Dividend Stock SSSGY or IFRX?
Sartorius AG has a quarterly dividend of $0.15 per share corresponding to a yield of 0.35%. InflaRx NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sartorius AG pays 32.05% of its earnings as a dividend. InflaRx NV pays out -- of its earnings as a dividend. Sartorius AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SSSGY or IFRX?
Sartorius AG quarterly revenues are $985.3M, which are larger than InflaRx NV quarterly revenues of $27.8K. Sartorius AG's net income of $72.5M is higher than InflaRx NV's net income of -$14.3M. Notably, Sartorius AG's price-to-earnings ratio is 100.66x while InflaRx NV's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sartorius AG is 3.85x versus 342.97x for InflaRx NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SSSGYSartorius AG3.85x 100.66x $985.3M $72.5M IFRXInflaRx NV342.97x -- $27.8K -$14.3M
-
Which has Higher Returns SSSGY or IMTX?
Immatics NV has a net margin of 7.35% compared to Sartorius AG's net margin of -974.45%. Sartorius AG's return on equity of 5.43% beat Immatics NV's return on equity of -25.21%.
Company Gross Margin Earnings Per Share Invested Capital SSSGYSartorius AG46.63% $0.15 $9.5B IMTXImmatics NV-- -$0.49 $508.8M -
What do Analysts Say About SSSGY or IMTX?
Sartorius AG has a consensus price target of --, signalling downside risk potential of --. On the other hand Immatics NV has an analysts' consensus of $18.75 which suggests that it could grow by 82.57%. Given that Immatics NV has higher upside potential than Sartorius AG, analysts believe Immatics NV is more attractive than Sartorius AG.
Company Buy Ratings Hold Ratings Sell Ratings SSSGYSartorius AG0 0 0 IMTXImmatics NV9 0 0 -
Is SSSGY or IMTX More Risky?
Sartorius AG has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Immatics NV has a beta of 1.361, suggesting its more volatile than the S&P 500 by 36.134%.
-
Which is a Better Dividend Stock SSSGY or IMTX?
Sartorius AG has a quarterly dividend of $0.15 per share corresponding to a yield of 0.35%. Immatics NV offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Sartorius AG pays 32.05% of its earnings as a dividend. Immatics NV pays out -- of its earnings as a dividend. Sartorius AG's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SSSGY or IMTX?
Sartorius AG quarterly revenues are $985.3M, which are larger than Immatics NV quarterly revenues of $6.1M. Sartorius AG's net income of $72.5M is higher than Immatics NV's net income of -$59.1M. Notably, Sartorius AG's price-to-earnings ratio is 100.66x while Immatics NV's PE ratio is 42.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Sartorius AG is 3.85x versus 13.72x for Immatics NV. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SSSGYSartorius AG3.85x 100.66x $985.3M $72.5M IMTXImmatics NV13.72x 42.21x $6.1M -$59.1M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 22
Lamb Weston Holdings, Inc. [LW] is down 2.59% over the past day.
Buy
54
BMRN alert for Dec 22
BioMarin Pharmaceutical, Inc. [BMRN] is down 3.03% over the past day.
Buy
82
RKLB alert for Dec 22
Rocket Lab Corp. [RKLB] is up 9.97% over the past day.
